Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity

ClinicalTrials.gov ID: NCT01852058

Public ClinicalTrials.gov record NCT01852058. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-term Extension Study of BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age

Study identification

NCT ID
NCT01852058
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allergan
Industry
Enrollment
95 participants

Conditions and interventions

Interventions

  • OnabotulinumtoxinA Biological

Biological

Eligibility (public fields only)

Age range
5 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 10, 2014
Primary completion
Nov 21, 2018
Completion
Oct 2, 2019
Last update posted
May 11, 2020

2014 – 2019

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
University of Alabama at Birmingham Division of Urology Research Office Birmingham Alabama 35294
Cedars-Sinai Medical Center Los Angeles California 90048
Children's Hospital of Orange County Orange California 92868
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
Riley Hospital for Children Indianapolis Indiana 46032
William Beaumont Hospital Research Institute Royal Oak Michigan 48073
St. Louis Children's Hospital Division of Urology St Louis Missouri 63110
Pediatric Urology Associates, PC Tarrytown New York 10591
McKay Urology Carolinas Medical Center Charlotte North Carolina 28207
Duke University Durham North Carolina 27705
Cincinnati Children's Hospital Medical Center Cincinnati Center for Clinical Research and Outpatient Clinic Cincinnati Ohio 45229
Oklahoma Children's Hospital Oklahoma City Oklahoma 73104
Medical University of South Carolina Charleston South Carolina 29425
Children's Hospital of Wisconsin Department of Pediatric Urology Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01852058, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01852058 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →